Laurent Hocqueloux

Researcher Next ID · RN-021444

Researcher · Immunology and Microbiology

Orléans, Vietnam

Not currently recruitingFunding unknown

Research interests

Immunology and Microbiology

Medicine

HIV Research and Treatment

HIV/AIDS drug development and treatment

HIV/AIDS Research and Interventions

HIV-related health complications and treatments

SARS-CoV-2 and COVID-19 Research

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Nature Medicine · 2021 · https://doi.org/10.1038/s41591-021-01318-5
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Nature · 2021 · https://doi.org/10.1038/s41586-021-04389-z
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Nature · 2021 · https://doi.org/10.1038/s41586-021-03777-9
Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
The Journal of Infectious Diseases · 2014 · https://doi.org/10.1093/infdis/jiu051
Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1215541
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
PLoS Pathogens · 2013 · https://doi.org/10.1371/journal.ppat.1003211

No projects listed.